An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Professionals Express Worries
However, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some professionals stated the demand for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.
Service Reaction and Content Elimination
According to TikTok, the platform has taken down problematic material and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at residence.
Within moments of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.
Item Information and Pricing
Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram said it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her team has already seen patients harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.
